文献速递临床试验与 GCP流行病学与生物统计

选择性消化道去污染对接受机械通气的危重患者院内死亡率的影响:一项随机临床试验

Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2022-01-01

这项在澳大利亚19个ICU开展的整群交叉随机临床试验纳入5982例机械通气成人,比较选择性消化道去污染(SDD)与标准护理对90天内院内死亡率的影响。SDD组院内死亡27.0%,标准护理组29.1%,差异未达统计学显著(OR 0.91,95%CI 0.82-1.02,P=0.12),但效应估计的置信区间包含临床重要获益。

要点

  • SDD未显著降低机械通气危重患者的院内死亡率(27.0% vs 29.1%,P=0.12)。
  • SDD组新发抗生素耐药菌培养比例23.1%,低于标准护理组的34.6%。
  • 生态学评估中SDD在降低新发抗生素耐药菌比例方面未显示非劣效。

核心结论

  • 在接受机械通气的危重患者中,与不使用SDD的标准护理相比,SDD未显著降低院内死亡率,但效应估计的置信区间包含临床重要获益。

研究设计与样本

  • 整群交叉随机临床试验,从澳大利亚19个ICU招募5982例机械通气成人,招募时间为2018年4月至2021年5月,最终随访至2021年8月。
  • 同期生态学评估从参与ICU招募8599例患者,时间为2017年5月至2021年8月。
  • ICU被随机分配在2个交替的12个月期间采用或不采用SDD策略,期间间隔3个月。

主要发现

  • SDD组院内死亡753/2791(27.0%),标准护理组928/3191(29.1%),平均差异-1.7%(95%CI -4.8%至1.3%),OR 0.91(95%CI 0.82-1.02),P=0.12。
  • 8个预设次要结局中6个无显著差异。
  • SDD组 vs 标准护理组新发抗生素耐药菌培养比例23.1% vs 34.6%(绝对差异-11.0%,95%CI -14.7%至-7.3%)。
  • SDD组 vs 标准护理组新发血培养阳性比例5.6% vs 8.1%(绝对差异-1.95%,95%CI -3.5%至-0.4%)。
  • SDD组 vs 标准护理组新发艰难梭菌感染比例0.5% vs 0.9%(绝对差异-0.24%,95%CI -0.6%至0.1%)。

关键数值与推荐

  • 主要结局为90天内院内死亡率。
  • 生态学评估对包括新发抗生素耐药菌培养在内的3个结局预设2%的非劣效界值。
  • 生态学评估第一期间新发抗生素耐药菌比例变化-3.3% vs -1.59%(平均差异-1.71%,单侧97.5%CI -∞至4.31%),第二期间0.88% vs 0.55%(平均差异-0.32%,单侧97.5%CI -∞至5.47%),SDD未显示非劣效。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Whether selective decontamination of the digestive tract (SDD) reduces mortality in critically ill patients remains uncertain. OBJECTIVE: To determine whether SDD reduces in-hospital mortality in critically ill adults. DESIGN, SETTING, AND PARTICIPANTS: A cluster, crossover, randomized clinical trial that recruited 5982 mechanically ventilated adults from 19 intensive care units (ICUs) in Australia between April 2018 and May 2021 (final follow-up, August 2021). A contemporaneous ecological assessment recruited 8599 patients from participating ICUs between May 2017 and August 2021. INTERVENTIONS: ICUs were randomly assigned to adopt or not adopt a SDD strategy for 2 alternating 12-month periods, separated by a 3-month interperiod gap. Patients in the SDD group (n = 2791) received a 6-hourly application of an oral paste and administration of a gastric suspension containing colistin, tobramycin, and nystatin for the duration of mechanical ventilation, plus a 4-day course of an intravenous antibiotic with a suitable antimicrobial spectrum. Patients in the control group (n = 3191) received standard care. MAIN OUTCOMES AND MEASURES: The primary outcome was in-hospital mortality within 90 days. There were 8 secondary outcomes, including the proportion of patients with new positive blood cultures, antibiotic-resistant organisms (AROs), and Clostridioides difficile infections. For the ecological assessment, a noninferiority margin of 2% was prespecified for 3 outcomes including new cultures of AROs. RESULTS: Of 5982 patients (mean age, 58.3 years; 36.8% women) enrolled from 19 ICUs, all patients completed the trial. There were 753/2791 (27.0%) and 928/3191 (29.1%) in-hospital deaths in the SDD and standard care groups, respectively (mean difference, -1.7% [95% CI, -4.8% to 1.3%]; odds ratio, 0.91 [95% CI, 0.82-1.02]; P = .12). Of 8 prespecified secondary outcomes, 6 showed no significant differences. In the SDD vs standard care groups, 23.1% vs 34.6% had new ARO cultures (absolute difference, -11.0%; 95% CI, -14.7% to -7.3%), 5.6% vs 8.1% had new positive blood cultures (absolute difference, -1.95%; 95% CI, -3.5% to -0.4%), and 0.5% vs 0.9% had new C difficile infections (absolute difference, -0.24%; 95% CI, -0.6% to 0.1%). In 8599 patients enrolled in the ecological assessment, use of SDD was not shown to be noninferior with regard to the change in the proportion of patients who developed new AROs (-3.3% vs -1.59%; mean difference, -1.71% [1-sided 97.5% CI, -∞ to 4.31%] and 0.88% vs 0.55%; mean difference, -0.32% [1-sided 97.5% CI, -∞ to 5.47%]) in the first and second periods, respectively. CONCLUSIONS AND RELEVANCE: Among critically ill patients receiving mechanical ventilation, SDD, compared with standard care without SDD, did not significantly reduce in-hospital mortality. However, the confidence interval around the effect estimate includes a clinically important benefit. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02389036.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Myburgh JA, Seppelt IM, Goodman F, et al. Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial. JAMA. 2022. PMID: 36286097. doi:10.1001/jama.2022.17927

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。